A pair of pilot programs recently introduced by CMS aims to reduce Medicare spending on prescription drugs as well as ...
CMS proposes GUARD and GLOBE models to benchmark Medicare drug prices to international levels, aiming to cut costs and reduce ...
The Centers for Medicare & Medicaid Services (CMS) recently proposed the Guarding US Medicare Against Rising Drug Costs (GUARD) Model, a drug payment model that aims to distribute rebates for certain ...
The Centers for Medicare & Medicaid Services (CMS) has proposed two more programmes in the Trump administration's efforts to ...
CMS has proposed two new models aimed at curbing Medicare drug spending by linking payments to international benchmarks. The proposals — GUARD for Part D drugs and GLOBE for Part B — are the latest in ...
The Centers for Medicare & Medicaid Services released details of its proposal to address the expensive costs of Medicare Part B.
The Trump administration proposed new payment cuts in Medicare for prescription drugs, even as pharmaceutical companies ...
The report estimates that out-of-pocket costs for the 10 drugs will fall nearly 50% in 2026 versus 2025 in all 56 stand-alone prescription drug plans in California, Florida, Texas, New York, and ...
As the U.S. works several levers to lower drug pricing, such as Medicare negotiating costs with drugmakers and President Donald Trump launching TrumpRx, a report from the IQVIA Institute quantified ...
Blame medical inflation and more people in need of costly care for the 9.7% jump in Medicare Part B premiums next year. Starting in January, people on Medicare will pay $202.90 in 2026 for their ...
Medicare expenditures for patients with amyotrophic lateral sclerosis are more than 3 times those of the average Medicare beneficiary, and drug therapies are an important cost driver. Objectives: To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback